Hanson & Doremus Investment Management Elevance Health, Inc. Transaction History
Hanson & Doremus Investment Management
- $627 Million
- Q3 2024
A detailed history of Hanson & Doremus Investment Management transactions in Elevance Health, Inc. stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 176 shares of ELV stock, worth $71,061. This represents 0.01% of its overall portfolio holdings.
Number of Shares
176
Previous 176
-0.0%
Holding current value
$71,061
Previous $95,000
4.21%
% of portfolio
0.01%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding ELV
# of Institutions
1,861Shares Held
198MCall Options Held
1.03MPut Options Held
1.24M-
Vanguard Group Inc Valley Forge, PA21.3MShares$8.62 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY20.7MShares$8.36 Billion0.26% of portfolio
-
State Street Corp Boston, MA10.7MShares$4.32 Billion0.23% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.2MShares$4.1 Billion0.61% of portfolio
-
Geode Capital Management, LLC Boston, MA4.85MShares$1.96 Billion0.21% of portfolio
About Elevance Health, Inc.
- Ticker ELV
- Exchange NYSE
- Sector Healthcare
- Industry Healthcare Plans
- Shares Outstandng 240,000,992
- Market Cap $96.9B
- Description
- Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....